Anne McGeorge

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Anne McGeorge
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anne McGeorge:

Company Role Class Num Shares Value Price $ Report Date Ownership
Oncology Institute, Inc. Director Common Stock 291,370 $1,343,215 $4.61 20 Nov 2025 Direct
Dianthus Therapeutics, Inc. /DE/ Director Stock Option (Right to Buy) 12,500 22 May 2025 Direct
SOC Telemed, Inc. Former Director Class A Common Stock 0 $3.00 06 Apr 2022 Direct

Insider Reports Filed by Anne McGeorge

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TOI Oncology Institute, Inc. 20 Nov 2025 2 $0 4 Director 24 Nov 2025, 17:26
DNTH Dianthus Therapeutics, Inc. /DE/ 22 May 2025 1 $0 4 Director 22 May 2025, 16:41
TOI Oncology Institute, Inc. 22 Nov 2024 1 $0 4 Director 25 Nov 2024, 16:28
DNTH Dianthus Therapeutics, Inc. /DE/ 23 May 2024 1 $0 4 Director 28 May 2024, 19:58
TOI Oncology Institute, Inc. 26 Dec 2023 1 $0 4 Director 28 Dec 2023, 17:06
DNTH Dianthus Therapeutics, Inc. /DE/ 11 Sep 2023 1 $0 4 Director 13 Sep 2023, 22:14
TOI Oncology Institute, Inc. 17 Mar 2023 1 $0 4 Director 21 Mar 2023, 20:47
TOI Oncology Institute, Inc. 17 Nov 2022 1 $0 4 Director 21 Nov 2022, 16:33
DNTH Magenta Therapeutics, Inc. 28 Jun 2022 1 $0 4 Director 30 Jun 2022, 18:33
/report/000120919122023675-mcgeorge-anne-2022-04-06 SOC Telemed, Inc. 06 Apr 2022 1 -$175,161 4 Former Director 07 Apr 2022, 16:26
TOI Oncology Institute, Inc. 21 Mar 2022 2 $0 4 Director 23 Mar 2022, 19:34
TOI Oncology Institute, Inc. 12 Nov 2021 0 $0 3 Director 16 Nov 2021, 18:47
/report/000120919121038698-mcgeorge-anne-2021-06-03 SOC Telemed, Inc. 03 Jun 2021 1 $0 4 Director 07 Jun 2021, 17:07
DNTH Magenta Therapeutics, Inc. 01 Jun 2021 1 $0 4 Director 03 Jun 2021, 18:36